Acumen Pharmaceuticals (United States)
ORCID: 0000-0001-7125-1550Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Hugo Vandeerstichele, Magdalena Korecka, Christopher M. Clark, Paul S. Aisen, Ronald C. Petersen +14 more
Driven by 9 papers — median percentile 77. Top paper: “Revised criteria for the diagnosis and staging of Alzheimer’s disease”.
Scott J. Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf +15 more
Paul S. Aisen, David A. Bennett, Suzanne Craft, Anne M. Fagan, Takeshi Iwatsubo +18 more
J. Scott Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf +15 more
Michael Donohue, Rema Raman, Chung‐Kai Sun, R. Yaari, Karen C. Holdridge +5 more
Hugo Vandeerstichele, Magdalena Korecka, Christopher M. Clark, Paul S. Aisen, Ronald C. Petersen +14 more
Kejal Kantarci, Eric M Reiman, William E Klunk, Michael W Weiner, Henrik Zetterberg +6 more
Hao Wu, Wenbiao Xian, Yifan Zheng, Wenxuan Du, Xinyi Chen +1916 more
Eline Appelmans, Ramona Burress, Susan De Santi, Theresa Devins, Gregory Klein +14 more
for the Alzheimer’s Disease Neuroimaging Initiative, Eric Siemers, Paul Maruff, Ronald C. Petersen, Paul Aisen +3 more